Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium oxalate crystal is a mineral composed of calcium cations and oxalate anions, with the basic formula CaC₂O₄, often forming as monohydrate (COM; whewellite), dihydrate (COD; weddellite), or trihydrate (caoxite)[5][7][1]. It forms the major mineral component (∼76%) of human kidney stones and can also be found as a controlled biomineral in plants, where it plays roles in calcium storage and defense[4][8]. In pathology, crystals precipitate when urine or tissue fluid reaches supersaturation, causing stone formation or tissue deposition. In plants, specialized cells tightly regulate the morphology and localization of crystals. Therapies for stone prevention frequently target either the physicochemical environment to prevent precipitation or use agents that modify crystal growth and aggregation[2][6].
Drugs such as citrate increase calcium solubility or inhibit crystal aggregation/growth[2]; polyphosphates prevent nucleation or embed in the crystal lattice to disrupt further growth[2]; thiazides reduce urinary calcium excretion, lessening supersaturation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium oxalate crystal.